Product
Liposomal mitoxantrone hydrochloride and Pegaspargase
Aliases
Part 2 (relapsed or refractory patients), Part 2 (relapsed or refractory patients): Liposomal mitoxantrone hydrochloride and Pegaspargase, Part 2 (treatment-naïve patients), Part 2 (treatment-naïve patients): Liposomal mitoxantrone hydrochloride and Pegaspargase
1 clinical trial
2 indications
Indication
Extranodal NK/T-cell LymphomaIndication
Nasal TypeClinical trial
A Multicentre, Open-label, Single-arm, Phase I/II Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCLStatus: Terminated, Estimated PCD: 2022-01-30